✦ LIBER ✦

Treatment of Cyclosporine-Related Adverse Effects by Conversion to Tacrolimus After Liver Transplantation: Long-Term Results

✍ Scribed by J Pratschke; R Neuhaus; S.G Tullius; S Jonas; W.O Bechstein; P Neuhaus

Book ID: 117236145
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 157 KB
Volume: 30
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(98)00298-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of tacrolimus-related adverse

Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients

✍ Sukru Emre; Yuri Genyk; Leona Kim Schluger; Thomas M. Fishbein; Stephen R. Guy; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 599 KB

Treatment of tacrolimus-related adverse

Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients

✍ S. Emre; Y. Genyk; L. K. Schluger; T. M. Fishbein; S. R. Guy; P. A. Sheiner; M. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 63 KB

Conversion to neoral for tacrolimus-rela

Conversion to neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life

✍ R.H. Tolba; B. Wrigge; U. Machein; T. Minor; J.C. Kalff; A. Hirner; M. Wolff 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Does conversion of immunosuppressive mon

Does conversion of immunosuppressive monotherapy from cyclosporine a to tacrolimus improve bone mineral density in long-term stable liver transplant recipients?

✍ R Ott; M Bussenius-Kammerer; C.A Koch; S Yedibela; H Kissler; W Hohenberger; V M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Regression of new-onset diabetes mellitu

Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: Results of a pilot study

✍ R. Lorho; J. Hardwigsen; J. Dumortier; G.-P. Pageaux; F. Durand; T. Bizollon; A. 📂 Article 📅 2011 🏛 Elsevier 🌐 French ⚖ 188 KB

Long-term effects of calcineurin inhibit

Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation

✍ Caroline Créput; Frederique Blandin; Benjamin Deroure; Bruno Roche; Faouzi Salib 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Calcineurin inhibitors (CNIs) are the cornerstone of immunosuppression after liver transplantation. However, CNI treatment is frequently associated with chronic renal failure (CRF). The reduction or interruption of CNI may reduce renal failure. We prospectively studied 49 liver recipients treated wi